Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense oligonucleotides as a tool for gene functionalization and target validation

C F Bennett1, L M Cowsert

  • 1ISIS Pharmaceuticals, Carlsbad, CA 92008, USA. fbennett@isisph.com

Biochimica Et Biophysica Acta
|May 12, 2000
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combinatorial ASO-mediated therapy with low dose SMN and the protective modifier Chp1 is not sufficient to ameliorate SMA pathology hallmarks.

Neurobiology of disease·2022
Same author

Pharmacology of antisense therapeutic agents : cancer and inflamination.

Methods in molecular medicine·2011
Same author

Case report; rabies in a heifer.

The British veterinary journal·2010
Same author

Antisense oligonucleotide therapeutics.

Expert opinion on investigational drugs·2005
Same author

Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma.

Leukemia·2004
Same author

Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes.

Gene therapy·2003